Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Evolent Health, Inc (EVH : NYSE)
 
 • Company Description   
Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia.

Number of Employees: 4,200

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.95 Daily Weekly Monthly
20 Day Moving Average: 2,792,670 shares
Shares Outstanding: 112.48 (millions)
Market Capitalization: $444.30 (millions)
Beta: 0.83
52 Week High: $12.07
52 Week Low: $2.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 33.90% 27.36%
12 Week 18.98% 9.99%
Year To Date -1.25% -11.74%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1812 NORTH MOORE ST SUITE 1705
-
ARLINGTON,VA 22209
USA		 ph: 571-389-6000
fax: 571-389-6001		 investorrelations@evolent.com http://www.evolent.com
 
 • General Corporate Information   
Officers
Seth Blackley - Chief Executive Officer
Mario Ramos - Chief Financial Officer
Aammaad Shams - Chief Accounting Officer
Craig Barbarosh - Director
Peter Grua - Director

Peer Information
Evolent Health, Inc (HLIS)
Evolent Health, Inc (AZTA)
Evolent Health, Inc (APYI)
Evolent Health, Inc (RNVA)
Evolent Health, Inc (HMSY)
Evolent Health, Inc (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 30050B101
SIC: 8741
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/06/26
Share - Related Items
Shares Outstanding: 112.48
Most Recent Split Date: (:1)
Beta: 0.83
Market Capitalization: $444.30 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.13 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.23 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.12
Price/Cash Flow: 0.84
Price / Sales: 0.24
EPS Growth
vs. Year Ago Period: -200.00%
vs. Previous Quarter: -300.00%
Sales Growth
vs. Year Ago Period: 2.60%
vs. Previous Quarter: 5.87%
ROE
03/31/26 - 0.36
12/31/25 - 1.49
09/30/25 - 1.79
ROA
03/31/26 - 0.10
12/31/25 - 0.49
09/30/25 - 0.65
Current Ratio
03/31/26 - 1.32
12/31/25 - 1.31
09/30/25 - 1.33
Quick Ratio
03/31/26 - 1.32
12/31/25 - 1.31
09/30/25 - 1.33
Operating Margin
03/31/26 - 0.12
12/31/25 - 0.62
09/30/25 - 0.80
Net Margin
03/31/26 - -26.29
12/31/25 - -28.49
09/30/25 - -6.24
Pre-Tax Margin
03/31/26 - -26.32
12/31/25 - -28.50
09/30/25 - -6.22
Book Value
03/31/26 - 3.52
12/31/25 - 3.53
09/30/25 - 7.55
Inventory Turnover
03/31/26 - -
12/31/25 - -
09/30/25 - -
Debt-to-Equity
03/31/26 - 2.46
12/31/25 - 2.34
09/30/25 - 1.25
Debt-to-Capital
03/31/26 - 71.06
12/31/25 - 70.04
09/30/25 - 55.60
 

Powered by Zacks Investment Research ©